These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Treatment of type II hyperlipoproteinaemia with cholestyramine. Schade RW; Laar A van't ; Jansen AP Neth J Med; 1973; 16(6):254-9. PubMed ID: 4767765 [No Abstract] [Full Text] [Related]
47. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia. Schapel GJ; Edwards KD; Neale FC Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384 [No Abstract] [Full Text] [Related]
48. [Diagnosis and treatment of primary hyperlipidemias]. Davignon J Arq Bras Cardiol; 1982 Jan; 38(1):59-68. PubMed ID: 6756360 [No Abstract] [Full Text] [Related]
49. An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate. Howard AN; Evans RJ; Hyams DE Med Chir Dig; 1972; 1(5):235-9. PubMed ID: 4631445 [No Abstract] [Full Text] [Related]
51. Treatment of essential hyperlipidaemia. Fredrickson DS; Levy RI Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
52. Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine. Kim DN; Lee KT; Reiner JM; Thomas WA Exp Mol Pathol; 1975 Aug; 23(1):83-95. PubMed ID: 1157892 [No Abstract] [Full Text] [Related]
53. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia. Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502 [TBL] [Abstract][Full Text] [Related]
54. [Hypercholesterinemia: treatment with Colestyramin]. Weizel A Fortschr Med; 1972 Jun; 90(18):715-8. PubMed ID: 5082079 [No Abstract] [Full Text] [Related]
55. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation]. Mann S; Maisenbacher HJ Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545 [No Abstract] [Full Text] [Related]
56. [Incidence of hyperlipoproteinemias, their classification and influencing through diet during a course of spa treatment. II. Clinical part]. Sachlová M; Hofman J; Zwetschke O Vnitr Lek; 1974 Jan; 20(1):15-27. PubMed ID: 4847012 [No Abstract] [Full Text] [Related]
57. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia. Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751 [TBL] [Abstract][Full Text] [Related]
58. The investigation and treatment of hyperlipidaemia in general practice. Tierney E Practitioner; 1975 Mar; 214(1281):393-6. PubMed ID: 1144258 [TBL] [Abstract][Full Text] [Related]
59. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
60. [Drug therapy of hyperlipidemic states]. Lipovetskiĭ BM; Triufanov VF; Konstantinov VO Klin Med (Mosk); 1980 Apr; 58(4):56-61. PubMed ID: 7382369 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]